News

Eubiotics Drugs Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 7, 2021

The global eubiotics drugs size is expected to reach USD 10.89 Billion in 2028 and register a CAGR of 8.0% over the forecast period, according to latest analysis by Emergen Research. The report provides eubiotics drugs forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. Key factors projected to drive market revenue growth include increasing global consumption of meat, specifically chicken, milk, and eggs owing to a rapidly growing global population, shift in dietary preferences, changing food consumption patterns, rising demand for manufactured feed, and increasing awareness about feed quality on livestock health and wellness. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/577

Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the eubiotics drugs. In addition, increasing incidence of poultry disease outbreaks have resulted in more stringent regulations and norms being implemented by governments, which is a factor prompting livestock farmers to increase focus on livestock health and shift towards more healthy feeds and additives. Global eubiotics drugs forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. eubiotics drugs forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/eubiotics-market

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “eubiotics drugs Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Some Key Highlights in the Report

On 10 December 2024, BASF and Adifo Software announced the launch of a new digital solution for the animal agriculture value chain. Integration of BASF’s sustainability analytics into Adifo’s BESTMIX feed formulation will enable customers along the animal agriculture value chain to strategically manage and optimize feed formulation based on nutrition and cost while taking environmental sustainability aspects into consideration.
In January 2019, Cargill’s European poultry business acquired Poland’s Konspol to provide value-added poultry products to global consumers.
The market in Asia Pacific is expected to register a comparatively faster revenue CAGR than other regional markets due to industrialization of livestock, growing population, and rising demand for meat in countries such as Japan, India, and China. In addition, development of various alternatives to traditional antibiotic growth promoter to enhance immune system of livestock in countries in the region is expected to support market growth going ahead.
Key players in the global eubiotics drugs are BASF SE, Novus International, Lallemand Inc., Cargill Inc., Koninklijke DSM NV, Kemin Industries, Lesaffre Group, Behn Mayer Group, Yara International ASA, and DuPont.

Request customized copy of Eubiotics report@ https://www.emergenresearch.com/request-for-customization/577

Region wise performance of the Eubiotics industry

North America eubiotics drugs forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America eubiotics drugs revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the eubiotics drugs forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe eubiotics drugs forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support eubiotics drugs growth.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Avail Discount on eubiotics drugs Report@ https://www.emergenresearch.com/request-discount/577

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Eubiotics industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the eubiotics drugs across different regions?
Who are the major driving forces expected to decide the fate of the Eubiotics industry worldwide?
Who are the prominent market players making a mark in the eubiotics drugs with their winning strategies?
Which Eubiotics industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the eubiotics drugs?

Why Choose Emergen Research?